Citigroup Inc Agios Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 24,317 shares of AGIO stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,317

Previous 194,480 87.5%

Holding current value

$1.11 Million

Previous $5.69 Million 81.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$27.55 - $48.83 $4.69 Million - $8.31 Million	-170,163 Reduced 87.5%	24,317 $1.05 Million
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $1.86 Million - $3.04 Million	87,252 Added 81.37%	194,480 $5.69 Million
Q4 2023 Feb 09, 2024	BUY	$19.97 - $24.53 $843,472 - $1.04 Million	42,237 Added 64.99%	107,228 $2.39 Million
Q3 2023 Nov 09, 2023	SELL	$24.36 - $28.18 $13,105 - $15,160	-538 Reduced 0.82%	64,991 $1.61 Million
Q2 2023 Aug 10, 2023	SELL	$21.38 - $29.19 $2.6 Million - $3.55 Million	-121,741 Reduced 65.01%	65,529 $1.86 Million
Q1 2023 May 11, 2023	BUY	$21.74 - $30.93 $2.02 Million - $2.88 Million	93,111 Added 98.89%	187,270 $4.3 Million
Q4 2022 Feb 09, 2023	SELL	$24.81 - $31.52 $837,610 - $1.06 Million	-33,761 Reduced 26.39%	94,159 $2.64 Million
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $190,495 - $333,342	-9,764 Reduced 7.09%	127,920 $3.62 Million
Q2 2022 Aug 10, 2022	BUY	$17.06 - $31.42 $1.8 Million - $3.32 Million	105,624 Added 329.46%	137,684 $3.05 Million
Q1 2022 May 12, 2022	SELL	$26.68 - $34.81 $3.23 Million - $4.21 Million	-120,994 Reduced 79.05%	32,060 $934,000
Q4 2021 Feb 10, 2022	BUY	$29.58 - $49.78 $2.9 Million - $4.88 Million	98,113 Added 178.58%	153,054 $5.03 Million
Q3 2021 Nov 10, 2021	BUY	$41.92 - $58.18 $2.3 Million - $3.2 Million	54,941 New	54,941 $2.54 Million

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account